Two Cryptic Self‐Resistance Mechanisms in Streptomyces tenebrarius Reveal Insights into the Biosynthesis of Apramycin
- 4 February 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 133 (16) , 9072-9078
Abstract
Apramycin is a clinically promising aminoglycoside antibiotic (AGA). To date, mechanisms underlying the biosynthesis and self‐resistance of apramycin remain largely unknown. Here we report that apramycin biosynthesis proceeds through unexpected phosphorylation, deacetylation, and dephosphorylation steps, in which a novel aminoglycoside phosphotransferase (AprU), a putative creatinine amidohydrolase (AprP), and an alkaline phosphatase (AprZ) are involved. Biochemical characterization revealed that AprU specifically phosphorylates 5‐OH of a pseudotrisaccharide intermediate, whose N‐7′ acetyl group is subsequently hydrolyzed by AprP. AprZ is located extracellularly where it removes the phosphate group from a pseudotetrasaccharide intermediate, leading to the maturation of apramycin. Intriguingly, 7′‐N‐acetylated and 5‐O‐phosphorylated apramycin that were accumulated in ΔaprU and ΔaprZ respectively exhibited significantly reduced antibacterial activities, implying Streptomyces tenebrarius employs C‐5 phosphorylation and N‐7′ acetylation as two strategies to avoid auto‐toxicity. Significantly, this study provides insight into the design of new generation AGAs to circumvent the emergence of drug‐resistant pathogens.Keywords
Funding Information
- National Key Research and Development Program of China (2018YFA0900400)
- National Natural Science Foundation of China (31870035)
- Fundamental Research Funds for the Central Universities (2042020kf1077)
This publication has 48 references indexed in Scilit:
- Destination of aminoglycoside antibiotics in the ‘post-antibiotic era’The Journal of Antibiotics, 2017
- Aminoglycoside Antibiotics in the 21st CenturyACS Chemical Biology, 2012
- Biosynthetic genes for aminoglycoside antibioticsThe Journal of Antibiotics, 2009
- The Classic: Streptomycin, a Substance Exhibiting Antibiotic Activity against Gram-Positive and Gram-Negative BacteriaClinical Orthopaedics and Related Research, 2005
- Combating Drug-Resistant Bacteria: Small Molecule Mimics of Plasmid Incompatibility as Antiplasmid CompoundsJournal of the American Chemical Society, 2004
- Molecular recognition of aminoglycoside antibiotics by ribosomal RNA and resistance enzymes: An analysis of x‐ray crystal structuresBiopolymers, 2003
- Versatility of Aminoglycosides and Prospects for Their FutureClinical Microbiology Reviews, 2003
- Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibioticsNature, 2000
- Effects of Apramycin, a Novel Aminoglycoside Antibiotic on Bacterial Protein SynthesisEuropean Journal of Biochemistry, 1979
- Apramycin, a unique aminocyclitol antibioticThe Journal of Organic Chemistry, 1976